Chemclin Diagnostics Co., Ltd. (SHA:688468)
China
· Delayed Price · Currency is CNY 7.67
+0.21 (2.82%)
Mar 10, 2026, 11:29 AM CST
Chemclin Diagnostics Market Cap
Chemclin Diagnostics has a market cap or net worth of 2.94 billion as of March 9, 2026. Its market cap has increased by 5.37% in one year.
Market Cap
2.94B
Enterprise Value
2.32B
Revenue
353.32M
Ranking
n/a
PE Ratio
53.94
Stock Price
7.67
Market Cap Chart
Since April 9, 2021, Chemclin Diagnostics's market cap has decreased from 10.00B to 2.94B, a decrease of -70.57%. That is a compound annual growth rate of -22.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.98B | 3.00% |
| Dec 31, 2025 | 2.90B | 7.15% |
| Dec 31, 2024 | 2.70B | -37.53% |
| Dec 29, 2023 | 4.33B | 13.94% |
| Dec 30, 2022 | 3.80B | -47.15% |
| Dec 31, 2021 | 7.19B | -28.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medicalsystem Biotechnology | 3.92B |
| Guangdong Hybribio Biotech | 4.14B |
| Berry Genomics Co.,Ltd | 4.18B |
| Shanghai Labway Clinical Laboratory | 4.22B |
| Shanghai Rendu Biotechnology | 2.05B |
| Thalys Medical Technology Group | 4.78B |
| SMO ClinPlus CO.,LTD. | 5.06B |
| Cowealth Medical China | 6.80B |